Sweden: Herder steps into acting CEO role at Idogen as Karlsson moves on

Christina Herder, incoming CEO of Idogen

Anders Karlsson is leaving his position as CEO of Sweden-based Idogen to move to a role in another Swedish biotechnology company. He will remain in his current chair until September 1, 2022, while the board starts a process to recruit his successor. In the interim, Christina Herder, who has been a board member for more…

You must be a HMI Subscriber to view this content.

Subscribe Now »